biopharmaceutical company developing new treatments for obesity
Antag Therapeutics has raised €80M across 1 funding round from 7 investors, most recently a Series A round in Dec 2024. Based in Copenhagen, Denmark; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-04 | Series A | €80M |
| Dawn Biopharma,Export and Investment Fund of Denmark (EIFO),Longview Ventures,Novo Holdings,Pictet,SR One+1 more |
| View deal → |
